• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Bruce Kamich
    • Doug Kass
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • Trifecta Stocks
  1. Home
  2. / Investing
  3. / Stocks

Exhaustion? Not Much Evidence Just Yet

The market may need some rest and consolidation, but that doesn't mean it will produce a lot of downside.
By JAMES "REV SHARK" DEPORRE
Nov 26, 2019 | 10:46 AM EST
Stocks quotes in this article: GBT, CCXI, AUPH, BXRX, PING, DDOG

The bulls are looking for some upside follow through after strong action on Monday. A headline that White House Advisor Kellyanne Conway said "We're getting really close" to a deal on China helped to provide a temporary surge, but that spike appears to have attracted some sellers.

The contrarians are arguing that the expansion on Monday of strength to small-caps and high-beta names may have been too euphoric and may trigger some exhaustion. The logic is that when the buying spreads to more speculative groups it is an indication that buying power may be used up.

The timing of contrarian arguments is always extremely difficult and it is complicated further by the trading around the Thanksgiving holiday, which usually has a positive bias. We'll see what the market thinks about exhaustion by simply watching the price action. So far there isn't much evidence. The market may need some rest and consolidation, but that doesn't mean it will produce much downside.

The biotechnology group is particularly interesting here on Tuesday. Food and Drug Administration (FDA) approval of drugs from Global Blood Therapeutics Inc. (GBT) and ChemoCentryx Inc. (CCXI) surprised market players, which is leading to some speculation in other stocks that will have decisions soon on key drugs. Aurinia Pharmaceuticals Inc. (AUPH) and Baudax Bio Inc. (BXRX) are two that I've been following.

I've used strength to reduce some positions here on Tuesday morning, such as with Ping Identity Holding Corp. (PING) and Datadog Inc. (DDOG) . My cash levels have been much higher than I would like but my trade management has kept it that way as I take gains and have not been able to put cash to work fast enough.

Trading is going to slow quite a bit the rest of the week, but it is the pockets of momentum that will provide some entertainment. Here on Tuesday it is biotechnology that is the most lively.

Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

At the time of publication, Rev Shark was long AUPH and BXRX.

TAGS: Drug Approvals | Investing | Politics | Stocks | Biotechnology | Software & Services | China

More from Stocks

Bearish Bets: 3 Stocks You Should Think About Shorting This Week

Bob Lang
Jun 26, 2022 10:30 AM EDT

These recently downgraded names are displaying both quantitative and technical deterioration.

For Smith & Wesson, Load, Cock and Fire Another Round

Bret Jensen
Jun 26, 2022 7:30 AM EDT

Here's how to aim for this gunmaker once more with a covered-call play.

Does the Big Bounce Mean More to Come? Let's See What Drove the Move

James "Rev Shark" DePorre
Jun 24, 2022 4:42 PM EDT

Much of the rally can be attributed to structural reasons, not fundamentals, technicals, or even macro ones.

MongoDB Is Poised for a Rally

Bruce Kamich
Jun 24, 2022 2:15 PM EDT

Here's our initial upside price target for MDB which provides a general purpose database platform.

See That Down the Road? It's the Big 'Green' Bubble, Ready to Pop

Jim Collins
Jun 24, 2022 1:30 PM EDT

Environmental, social, and corporate governance has created a monster and gullible investors should hit the brakes on their EVs and run from the Washington technocrats while they have the chance.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 12:04 AM EDT PAUL PRICE

    Two Good Signs -- Especially for Small-Cap Investors

  • 12:10 AM EDT PAUL PRICE

    More Insider Buying in American Woodmark (AMWD)

    American Woodmark , which I've discussed here fr...
  • 08:55 AM EDT JAMES "REV SHARK" DEPORRE

    This Weekend on Real Money

    The 10 personality traits of successful traders an...
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2022 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login